Scholars Central

Review articlePublished 2018

Fourth generation technologies in pharmaceuticals-Revolutionizing healthcare

Authors: Rohan Limaye, Laya Kumar, Dr. Nimita Limaye

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The pharmaceutical industry, being a highly regulated industry, has been slow to adopt innovation. However, as a result of spiralling costs and an increasing mandate to control the same, as well as an increasing cognizance of the need to drive patient centricity, pharma has opened the doors to innovation. Fourth generation technologies, ranging from ‘earables’ to ‘digital pills’, ‘genomicbased AI augmented trials’ and ‘AI- driven drug disovery’, ‘virtual reality and virtual clinical trials’, pharma has come a long way. Yet challenges related to interoperability, data security, data privacy, data ownership and data sharing pose hurdles to this path. This paper explores how fourth generation technologies are disrupting pharma and healthcare and empowering the patient. A slow adopter, pharma has gradually begun opening its doors to technology and evaluating new operating models to drive a paradigm shift from ‘an internal focus’ to an externalized ‘healthcare for you’ approach, prioritizing the needs of the patient. The very fact that the FDA approved 51 connected health products in 2017, demonstrates clearly that while science is the backbone, the Internet of Things (IoT) is the game-changer. It is no longer just about one device or one tool, but about systems ‘speaking to each other’ and data flowing real-time and seamlessly between systems, and about analytics being leveraged to obtain meaningful, holistic, point of care insights. Digital transformation is now an integral part of corporate strategy and it has been estimated that within five years, 80% of companies would have digitized at last some part of their value chain. Indeed, with the current $55 billion global digital health market expected to grow at 21.4% per year, it has been rightly said that the patient journey is ripe for digital disruption. Visit for more related articles at Journal of Systems Biology & Proteome Research

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Systems Biology & Proteome Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Systems Biology & Proteome Research
  • SubjectMathematics & Statistics
  • BylineArticles whose byline prints “Rohan Limaye”
  • BylineArticles whose byline prints “Laya Kumar”
  • BylineArticles whose byline prints “Dr. Nimita Limaye”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels